24 results
8-K
EX-10.1
GOSS
Gossamer Bio Inc
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
conditions of approval and policies imposed by any institutional review board, ethics review board or committee responsible for the oversight
PRE 14A
GOSS
Gossamer Bio Inc
17 Apr 23
Preliminary proxy
4:01pm
;
reviewing and approving any related party transactions and reviewing and monitoring compliance with our code of conduct and ethics; and
reviewing … , appointing) such candidates, will take into account many factors, including the following:
personal and professional integrity, ethics and values
424B5
wn3v9xxpvr1id0to
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
p7mxl0r8q2bcm8sxd8
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
em6ysz1 h0al0m8ae
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
htj7z jpcfe1d
18 May 20
Prospectus supplement for primary offering
4:11pm
DEF 14A
is61pp7k
30 Apr 19
Definitive proxy
4:04pm
10-K
nhm uwk0hfjs12y1fpbp
22 Mar 19
Annual report
4:45pm
424B4
vspbz6rqv
8 Feb 19
Prospectus supplement with pricing info
4:40pm